• Bluecore raises $50M for its first-party, AI-based marketing automation tools
    TechCrunch

    Bluecore raises $50M for its first-party, AI-based marketing automation tools

    As more online brands look for ways to move beyond third-party cookies as a way of gaining more direct insights about their users and customers, a startup that has developed a platform to help them has raised a big round of funding. Bluecore, a marketing technology firm that uses data gained from direct marketing like email, social media, site activity and combines that with machine learning to make better predictions about who might want to buy what among its customers, is today announcing that it has raised $50 million. The funding will be used to build the next generation of the Bluecore platform, expected later this year, which will tap into aggregated engagement data (but not actual browsing individuals) from "hundreds" of brands, which customers can combine with their own first-party data -- based on consent-based, first-party customer IDs -- to develop better targeting insights.

  • A new Android bug, Strandhogg 2.0, lets malware pose as real apps and steal user data
    TechCrunch

    A new Android bug, Strandhogg 2.0, lets malware pose as real apps and steal user data

    Security researchers have found a major vulnerability in almost every version of Android, which lets malware imitate legitimate apps to steal app passwords and other sensitive data. The vulnerability, dubbed Strandhogg 2.0 (named after the Norse term for a hostile takeover) affects all devices running Android 9.0 and earlier. It's the "evil twin" to an earlier bug of the same name, according to Norwegian security firm Promon, which discovered both vulnerabilities six months apart.

  • Barrons.com

    Covid-19 and Vaccine News Drive Boeing Stock Now. But Don’t Forget the MAX.

    The MAX drama isn’t over and Wall Street is still trying to figure out what it will mean to Boeing shares in the near future.

  • Could Sirius XM Be a Millionaire-Maker Stock?
    Motley Fool

    Could Sirius XM Be a Millionaire-Maker Stock?

    Satellite radio veteran Sirius XM (NASDAQ: SIRI) has made millionaires before. Sirius XM saw its annual revenues rise by 86% over the last five years. Pandora added $1.6 billion to Sirius's sales last year.

  • MarketWatch

    Dow surges 600 points, S&P 500 punches above key technical level as stock-market investors key on Novovax, Merck vaccine candidates

    U.S. stock benchmarks rallied Tuesday morning after Memorial Day weekend, as investors seized on fresh coronavirus vaccine news and signs that global economy was slowly starting to emerge from shutdowns induced by the viral pandemic. The Dow Jones Industrial Average jumped around 600 points, or 2.4%, at 25,040, the S&P 500 index climbed 2.1% at 3,016, which was approaching its 200-day moving average at 2,999.81--a level viewed by technical analysts as a key dividing line between long-term bullish and bearish trends. Meanwhile, the Nasdaq Composite Index climbed 1.7% at 9,477. On the corporate front, Novavax Inc. said it has started human trials of its vaccine candidate. The first phase of the placebo-controlled study will enroll 130 healthy adults; the first round of data from that study is expected in July. Big drugmaker Merck & Co. also said it is working on two potential vaccines and an experimental drug against the coronavirus, joining rivals in the frantic search for medicines. Meanwhile, the New York Stock Exchange, run by Intercontinental Exchange Inc. , is set to resume floor trading Tuesday.

  • Barrons.com

    Merck and Novavax Are Lifting the Stock Market, but Regeneron is Sliding. Here’s Why.

    Wall Street returned from the three-day holiday weekend in a buying mood. Stocks are higher around the world.

  • 3 Dividend Stocks Ideal for Retirees
    Motley Fool

    3 Dividend Stocks Ideal for Retirees

    Dividend stocks are a great option for a retirement account since you're earning income simply for holding shares. The coronavirus pandemic caused many companies to cut or cancel dividends. While other businesses saw substantial revenue declines from the current economic slowdown, there were at least three that delivered revenue and dividend increases in these tough economic times.

  • Barrons.com

    The Dow Is Rising Because Vaccines Are In the News Again

    There were two big announcements on the Covid-19 front—and they’re helping to lift the stock market on Tuesday morning.

  • Covid Report: Merck Joins Coronavirus Vaccine Hunt With Two-Pronged Strategy
    Investor's Business Daily

    Covid Report: Merck Joins Coronavirus Vaccine Hunt With Two-Pronged Strategy

    Shares of Dow Jones pharma giant Merck and Novavax jumped Tuesday after the drugmakers announced updated plans for coronavirus vaccines.

  • Reuters

    US STOCKS-Wall St set to surge at open on recovery, vaccine hopes

    Wall Street was set to surge at the open, with the S&P 500 poised to breach a major technical barrier on Tuesday as business restarts and optimism about a potential coronavirus vaccine helped investors overlook Sino-U.S. tensions. U.S. biotech group Novavax Inc jumped nearly 16% in premarket trading as it joined the race to test coronavirus vaccine candidates on humans and enrolled its first participants.

  • California Held Back the Promised Reopening Guidelines for Movie Production This Week
    Motley Fool

    California Held Back the Promised Reopening Guidelines for Movie Production This Week

    Gov. Gavin Newsom was eager to get film studios back in action, but his office respected a more safety-focused attitude from industry insiders.

  • Reuters

    Softbank's Arm releases chip tech for high-end Android devices

    Arm's technology powers the processors in both iPhones and Android devices. Apple's iPhones, however, are believed to have at least one high-performance core that is larger than others, helping it beat out Android competitors' peak speeds on single-threaded computing tasks.

  • MarketWatch

    Coronavirus pressures could prompt 14% drop in device shipments this year, says Gartner

    Worldwide shipments of personal computers, tablets, and mobile phones are expected to drop 13.6% this year to 1.9 billion units, according to a new forecast from Gartner analysts. They expect a 10.5% decline in PC shipments over the course of 2020, a decline that they said could have been "much worse" if not for government lockdowns that drove demand for equipment that would allow people to work and study from home. The Gartner analysts predict a 14.6% fall in mobile phone shipments and a 13.7% decline in smartphone shipments that could help extend the average phone lifetime to 2.7 years in 2020 from 2.5 years in 2018. They project that "only" 11% of mobile phone shipments this year will be 5G devices. "In 2020, affordable 5G phones were expected to be the catalyst to increase phone replacements, but it will not be the case" the analysts said in a release. Apple Inc. is expected to launch its first 5G devices later this year.

  • Novavax Begins Clinical Study for Coronavirus Vaccine
    Zacks

    Novavax Begins Clinical Study for Coronavirus Vaccine

    Novavax (NVAX) enrolls the first set of participants in a phase I/II clinical study for evaluating its coronavirus vaccine candidate, NVX-CoV2373.

  • Why Novavax Stock Is Skyrocketing Today
    Motley Fool

    Why Novavax Stock Is Skyrocketing Today

    Shares of Novavax (NASDAQ: NVAX), a clinical-stage vaccine company, are poised to continue their amazing run today. Novavax's shares are heating up yet again this morning in response to the official start of the combined phase 1/2 trial for the company's COVID-19 vaccine candidate, NVX‑CoV2373. Novavax's shares have now gained well over 1,000% since the start of 2020, thanks mainly to the excitement surrounding NVX‑CoV2373.

  • Latam Air Files Chapter 11 Bankruptcy, Stymied by Lockdowns
    Bloomberg

    Latam Air Files Chapter 11 Bankruptcy, Stymied by Lockdowns

    (Bloomberg) -- Latam Airlines Group SA, Latin America’s largest air carrier, sought bankruptcy court protection in New York after the Covid-19 pandemic grounded flights across the region.The Chapter 11 petition allows Latam to keep operating while the Chilean carrier works out a plan to pay creditors and turn around the business. Latam, whose shareholders include Chile’s Cueto family and Delta Air Lines Inc., is operating on a reduced schedule and has commitments for a bankruptcy loan of as much as $900 million.The money is coming from shareholders including the Cuetos, the Amaro family and Qatar Airways, according to a company statement. Latam also has about $1.3 billion in cash on hand.Airlines the world over -- and those in Latin America in particular -- have been hit hard by the coronavirus outbreak, which triggered travel bans and made people reluctant to fly. Avianca Holdings SA, the largest air carrier in Colombia, filed for Chapter 11 bankruptcy earlier in May, burdened by the sharp drop in fliers and its own onerous debt load.Latam’s affiliates in Brazil, Paraguay and Argentina aren’t part of the bankruptcy case, which was filed in the Southern District of New York.Still, the impact will be felt widely, with Santiago-based Latam previously serving more than 70 million passengers a year on more than 300 aircraft. It also carried more than $7 billion of debt.Latam has already eliminated more than 1,850 jobs in Chile, Colombia, Ecuador and Peru in recent weeks from its global workforce of about 40,000 people, after cutting 95% of its passenger operations. In some bankruptcy scenarios, an airline can reject aircraft leases, and Latam has more than 20 jetliners on order from Airbus SE and half a dozen from Boeing Co.“Exceptional circumstances have led to a collapse in global demand and has not only brought aviation to a virtual standstill, but it has also changed the industry for the foreseeable future,” Chief Executive Officer Roberto Alvo said in a statement.Latam listed assets of more than $21 billion and total liabilities of almost $18 billion in its bankruptcy petition.So far, Latam hasn’t had access to government bailout packages designed help offset virus-related distress. Talks are underway with governments in Chile, Brazil, Colombia and Peru about additional financing and assistance, the airline said.The Chilean government will evaluate the “convenience and opportunity to contribute to the success of Latam’s process,” the Finance Ministry said in a statement Tuesday.Brazilian BanThe task was made more urgent this past weekend by U.S. President Donald Trump’s order to restrict non-U.S. citizens arriving from Brazil to slow the spread of the coronavirus. Brazil accounts for about a third of Latam’s revenue.Latam traces its roots to Lan Airlines, founded in Chile in 1929 and privatized in 1989 during the last years of the Pinochet dictatorship. Latam was born in 2012 after Lan announced plans to merge with Tam for about $3.3 billion two years earlier.The Cueto family -- which is Latam’s largest shareholder and holds two seats on its board of directors -- acquired a stake in 1992 and control of the business in 1994. At that time, another major shareholder was current Chilean President Sebastian Pinera, who sold his own 26% stake early in his first term as president in 2010.Last year, Latam signed a $2.25 billion pact to sell a stake to Delta Air Lines, expanding Delta’s footprint in South America. The Chilean carrier has been planning to gradually ramp up flights over the next two months, with the goal of reaching 18% of pre-crisis capacity in July.Latam retained Cleary Gottlieb Steen & Hamilton as legal counsel, FTI Consulting Inc. as financial adviser and PJT Partners Inc. as investment banker.The case is Latam Airlines Group SA, 20-11254, U.S. Bankruptcy Court for the Southern District of New York (Manhattan)(Updates with Chilean Finance Ministry comment in the 11th paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Barrons.com

    Vaccines Are All That Matter for the Market and 5 More Things to Know

    Merck joins the vaccine race, U.S. hospitalizations are rising, China’s plan to amend Hong Kong law brings protestors back, and other news to start your day.

  • Dow Jones Futures Jump On Vaccine Hopes; Apple, Google Set To Break Out In Coronavirus Market Rally
    Investor's Business Daily

    Dow Jones Futures Jump On Vaccine Hopes; Apple, Google Set To Break Out In Coronavirus Market Rally

    Dow Jones futures surged as vaccine hopes fuel the hot coronavirus market rally. Apple, Google are set to breakout. Tesla and AMD are near buy points.

  • Here’s why Warren Buffett made a huge mistake selling his airline stocks
    MarketWatch

    Here’s why Warren Buffett made a huge mistake selling his airline stocks

    There’s a big debate now about whether Warren Buffett has “lost his touch.” While Buffett’s Berkshire Hathaway (BRK)(BRK) booked substantial losses dumping airlines stocks in the late first-quarter weakness in the sector, insiders at close to half a dozen airlines bought lots of their stock — including the airlines Berkshire sold. In a direct challenge to the Oracle of Omaha, insiders racked up the kind of sector-wide buying I look for to support a bullish industry call in my stock newsletter Brush Up on Stocks.

  • Analysts: 10 Winning Stocks Will Keep Leading From Here
    Investor's Business Daily

    Analysts: 10 Winning Stocks Will Keep Leading From Here

    If you missed the S&P; 500's powerful 32% two-month jump, don't worry. Analysts still think there's upside to some of the winners.

  • Pfizer Is Charging Ahead With A Coronavirus Vaccine — Is PFE Stock A Buy?
    Investor's Business Daily

    Pfizer Is Charging Ahead With A Coronavirus Vaccine — Is PFE Stock A Buy?

    Pfizer stock could see some gains in 2020 if it makes progress on a coronavirus vaccine with BioNTech. But its Upjohn merger with Mylan is now delayed. Is Pfizer stock a buy now?

  • AbbVie Wrapped Its $63 Billion Allergan Buyout — Is AbbVie Stock A Buy?
    Investor's Business Daily

    AbbVie Wrapped Its $63 Billion Allergan Buyout — Is AbbVie Stock A Buy?

    AbbVie stock recently broke out and the pharmaceutical company just wrapped its acquisition of Allergan. Is AbbVie stock a buy now?